New drug cocktail shows promise for tough head and neck cancers
NCT ID NCT05673577
First seen May 01, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This study tested a combination of three drugs (camrelizumab, cetuximab, and chemotherapy) as a first treatment for people with head and neck cancer that had come back or spread. 41 participants received the drug combo to see how many would have their tumors shrink or disappear. The goal was to control the disease, not cure it, and researchers also tracked side effects and how long people lived without the cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.